BCBSRI: Patient-centered medical home pilot program a success

A recently completed three-year pilot program intended to inform the design of a patient-centered medical home model yielded positive results, according to Blue Cross & Blue Shield of Rhode Island (BCBSRI).

The pilot program, which was developed by BCBSRI, involved 79 primary care providers who received partial funding for EHR implementation, monthly stipends and financial incentives for demonstrating improved quality.

According to a Dec. 12 BCBSRI statement, patients receiving care from participating providers enjoyed healthcare costs that averaged between 17 and 33 percent less than patients receiving care from non-participating providers.

The pilot also netted improved healthcare quality, with a 44 percent median rate of improvement in family and children’s health, 35 percent in women’s care and 24 percent in internal medicine, BCBSRI noted.


Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.